Cancer
Conditions
Keywords
Implantable central venous access ports, cancer
Brief summary
This is a prospective, descriptive and observational study of the anticancer center practice
Interventions
None listed
Sponsors
Centre Oscar Lambret
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient with any cancer, requiring a central venous catheter * No contraindication for any surgery with local or complete anaesthesia
Exclusion criteria
* Previous Xylocaine or Lidocaine allergy * Clinic superior vena cava syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change | Until the implantable central venous access ports removal |
Secondary
| Measure | Time frame |
|---|---|
| Brief description of the different risk factor for morbidity | Until the implantable central venous access ports removal |
| Assessment of the implantable central venous access ports ease-of-use for nurses according to the modalities of implementation and patient features | Until the implantable central venous access ports removal |
| Assessment of the patient quality of life | Before central venous access ports implementation, at the first day of chemotherapy, and during the cycle 4 of chemotherapy |
Countries
France
Outcome results
None listed